Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women

European Journal of Endocrinology

Volumn 136, Issue 5, 1997, Pages 483-487

  Arvat, E ^a   Gianotti, L ^a   Broglio, F ^a   Maccagno, B ^a   Bertagna, A ^a   Deghenghi, R ^b   Camanni, F ^a   Ghigo, E ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b Ardana   (France)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROCLIM; HEXARELIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; DRUG EFFECT; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0030983425     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360483     Document Type: Article

References (28)

1. Bowers CY, Veeraragavan K & Sethumadhavan K. Atypical growth hormone releasing peptides. In Growth Hormone II, Basic and Clinical Aspects, pp 203-222. Eds BB Bercu & RF Walker. New York: Springer-Verlag, 1993.
2. Ghigo E, Arvat E, Gianotti L, Grottoli S, Rizzi G, Ceda GP et al. Aging and GH-releasing peptides. In Growth Hormone Secretagogues. Serono Symposia, pp 415-431. Eds BB Bercu & RF Walker. New York: Springer-Verlag, 1996.
3. Walker RF, Yang AW, Masuda R, Hu CS & Bercu BB. Effects of growth hormone releasing peptides on stimulated growth hormone secretion in old rats. In Growth Hormone II, Basic and Clinical Aspects, pp 167-192. Eds BB Bercu & RF Walker. New York: Springer-Verlag, 1993.
4. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS & Thorner MO. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism 1990 70 975-982.
5. Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R et al. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. Journal of Clinical Endocrinology and Metabolism 1994 78 693-698.
6. Arvat E, Gianotti L, Di Vito L, Imbimbo BP, Lenaerts V, Deghenghi R et al. Modulation of growth hormone-releasing activity of Hexarelin in man. Neuroendocrinology 1995 61 51-56.
7. Corpas E, Harman SM & Blackman S. Human growth hormone and human aging. Endocrine Reviews 1993 14 20-39.
8. Arvat E, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R et al. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of Hexarelin in elderly subjects. Journal of Clinical Endocrinology and Metabolism 1994 79 1440-1443.
9. Ghigo E, Arvat E, Rizzi G, Bellone J, Nicolosi, Boffano GM et al. Arginine enhances the growth hormone (GH)-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration. Journal of Endocrinological Investigation 1994 17 157-162.
10. Chatelain P, Claris O, Lapillonne A, Dimayo M, Salle B et al. Fetal and neonatal somatotroph function. Frontiers in Paediatric Neuroendocrinology 1994 20 127-130.
11. Bellone J, Aimaretti G, Bartolotta E, Benso L, Imbimbo BP, Lenhaerts V et al. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, before and during puberty. Journal of Clinical Endocrinology and Metabolism 1995 80 1090-1094.
12. Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM & Templ H. Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. Journal of Clinical Endocrinology and Metabolism 1987 65 535-539.
13. Gelato MC, Pescovitz DH, Cassorla F, Loriaux DL & Merriam GR. Dose-response relationships for the effects of GH-releasing factor 1-44 NH2 in young adult men and women. Journal of Clinical Endocrinology and Metabolism 1984 59 197-203.
14. Smals AEM, Pieters GFFM, Smals AGH, Benraad TJ, van Laafhoven J & Kloppenborg PWC. Sex difference in human growth hormone (GH) response to intravenous human pancreatic GH-releasing hormone administration in young adults. Journal of Clinical Endocrinology and Metabolism 1986 62 336-340.
15. Penalva A, Pombo M, Carballo A, Barreiro J, Casanueva FF & Dieguez C. Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6. Clinical Endocrinology 1993 38 87-91.
16. 2 in the rat. Endocrinology 1985 117 1441-1447.
17. 2 (GHRP6)-induced GH secretion in the rat. Neuroendocrinology 1992 57 247-251.
18. Ho KY, Evans WS, Blizzard,RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL & Thorner MO. Effects of sex and age on the 24 hour secretory profile of GH cretion in man: Importance of endogenous estradiol concentrations. Journal af Clinical Endocrinology and Metabolism 1987 64 51-58.
19. Duursma SA, Bijlsma JWJ, Van Paassen HC, Van Buul-Offers SC & Skottner-Lundin A. Changes in serum somatomedin and growth hormone concentrations after 3 weeks estrogen substitution in post-menopausal women: a pilot study. Acta Endocrinologica 1984 106 527-531.
20. Dawson-Hughes B, Stern D, Goldman J & Reichlin S. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. Journal of Clinical Endocrinology and Metabolism 1986 63 424-432.
21. Kelly J, Rajkovic IA, O'Sullivan AJ, Sernia C & Ho KKY. Effects of different oral oestrogens on insulin-like growth factor-I, growth hormone binding protein in post-menopausal women. Clinical Endocrinology 1993 39 561-567.
22. Dall' Aglio E, Valenti G, Hoffman AR, Zuccarelli A, Passeri M & Ceda GP. Lack of effect of transdermal estrogen on the growth hormone-insulin-like growth factor axis. Hormones and Metabolic Research 1994 26 211-212.
23. Bellantoni MF, Harman SM, Cho DE & Blackman MR. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. Journal of Clinical Endocrinology and Metabolism 1991 72 172-178.
24. Lofstrom A, Eneroth P, Gustafsson E & Skett P. Effects of estradiol benzoate on catecholamine levels and the median eminence and the limbic forebrain, and on serum luteinizing hormone, follicle stimulating hormone and prolactin concentrations in the ovaiectomized female rat. Endocrinology 1977 101 1559-1562.
25. Stumpf WE, Sar M, Reisert I & Pilgrim C. Estrogen receptor sites in the developing central nervous system and their relationships to catecholamine systems. Monographs in Neural Science 1983 9 205-208.
26. Bowers CY, Sartor AO, Reynolds GA & Badger TM. On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991 128 2027-2035.
27. Conley LK, Teik JA, Deghenghi R, Imbimbo BP, Giustina A, Locatelli V et al. Mechanism of action of Hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology 1995 61 44-50.
28. Fairhall KM, Mynett A & Robinson ICAF. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. Journal of Endocrinology 1995 144 555-560.